<SEC-DOCUMENT>0001564590-21-027547.txt : 20210513
<SEC-HEADER>0001564590-21-027547.hdr.sgml : 20210513
<ACCEPTANCE-DATETIME>20210513161049
ACCESSION NUMBER:		0001564590-21-027547
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210513
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210513
DATE AS OF CHANGE:		20210513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Athira Pharma, Inc.
		CENTRAL INDEX KEY:			0001620463
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				453368487
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39503
		FILM NUMBER:		21919721

	BUSINESS ADDRESS:	
		STREET 1:		18706 NORTH CREEK PARKWAY, SUITE 104
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98011
		BUSINESS PHONE:		(425) 620-8501

	MAIL ADDRESS:	
		STREET 1:		18706 NORTH CREEK PARKWAY, SUITE 104
		CITY:			BOTHELL
		STATE:			WA
		ZIP:			98011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	M3 Biotechnology, Inc.
		DATE OF NAME CHANGE:	20140924
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>atha-8k_20210513.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-05-13T14:52:31.5824790+00:00 -->
<!-- Version            : 5.0.1.615 -->
<!-- Package ID         : 06e9c7c3886d43f3885db2f48ff1ed74 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:atha="http://m3bio.com/20210513" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
atha-8k_20210513.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001620463_20210513_20210513">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0001620463_20210513_20210513">0001620463</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="atha-20210513.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001620463_20210513_20210513">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001620463</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-05-13</xbrli:startDate>
					<xbrli:endDate>2021-05-13</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, DC 20549</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:35.16%;margin-right:35.16%;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001620463_20210513_20210513">8-K</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:35.16%;margin-right:35.16%;text-indent:0%;font-size:12pt;">&#160;</p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001620463_20210513_20210513" format="ixt:datemonthdayyearen">May 13, 2021</ix:nonNumeric></p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:35.16%;margin-right:35.16%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="font-weight:bold;font-size:24pt;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0001620463_20210513_20210513">Athira Pharma, Inc.</ix:nonNumeric></span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:35.16%;margin-right:35.16%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr style="height:14pt;">
<td valign="top" style="padding-left:3pt;padding-Right:3pt;width:33.34%;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001620463_20210513_20210513" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:3pt;padding-Right:3pt;width:33.34%;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0001620463_20210513_20210513">001-39503</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:3pt;padding-Right:3pt;width:33.34%;">
<p style="text-align:center;margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001620463_20210513_20210513">45-3368487</ix:nonNumeric></p></td>
</tr>
<tr style="height:20pt;">
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:33.34%;">
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</p>
<p style="text-align:center;margin-bottom:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:33.34%;">
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:33.34%;">
<p style="text-align:center;margin-top:2pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer</p>
<p style="text-align:center;margin-bottom:2pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityAddressAddressLine1" contextRef="C_0001620463_20210513_20210513">18706 North Creek Parkway</ix:nonNumeric>, <ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine2" contextRef="C_0001620463_20210513_20210513">Suite 104</ix:nonNumeric><br /><ix:nonNumeric id="F_000010" name="dei:EntityAddressCityOrTown" contextRef="C_0001620463_20210513_20210513">Bothell</ix:nonNumeric>, <ix:nonNumeric id="F_000011" name="dei:EntityAddressStateOrProvince" contextRef="C_0001620463_20210513_20210513">WA</ix:nonNumeric> <ix:nonNumeric id="F_000012" name="dei:EntityAddressPostalZipCode" contextRef="C_0001620463_20210513_20210513">98011</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, including zip code)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonNumeric id="F_000013" name="dei:CityAreaCode" contextRef="C_0001620463_20210513_20210513">425</ix:nonNumeric>) <ix:nonNumeric id="F_000014" name="dei:LocalPhoneNumber" contextRef="C_0001620463_20210513_20210513">620-8501</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Registrant&#8217;s telephone number, including area code)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:8pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report)</p>
<p style="text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:35.16%;margin-right:35.16%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:3.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000015" name="dei:WrittenCommunications" contextRef="C_0001620463_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:96.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:3.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:SolicitingMaterial" contextRef="C_0001620463_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:96.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:3.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:PreCommencementTenderOffer" contextRef="C_0001620463_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:96.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:3.52%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9.5pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001620463_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:96.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="margin-bottom:10pt;margin-top:10pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:35%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:30%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol(s)</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:35%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:3pt;padding-Right:3pt;width:35%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:Security12bTitle" contextRef="C_0001620463_20210513_20210513">Common Stock, $0.0001 par value per share</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:3pt;padding-Right:3pt;width:30%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:TradingSymbol" contextRef="C_0001620463_20210513_20210513">ATHA</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:3pt;padding-Right:3pt;width:35%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:SecurityExchangeName" contextRef="C_0001620463_20210513_20210513" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric> <br />(The Nasdaq Global Select Market)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr style="height:15pt;">
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:25%;">
<p style="margin-bottom:2pt;margin-top:2pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging Growth Company</p></td>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:75%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Segoe UI Symbol;letter-spacing:-0.1pt;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001620463_20210513_20210513" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9.5pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act).&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000023" name="dei:EntityExTransitionPeriod" contextRef="C_0001620463_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#160;</p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9.5pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><br /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.02 Results of Operations and Financial Condition.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:7.03%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 13, 2021, Athira Pharma, Inc. (the &#8220;Company&#8221;) issued a press release reporting its financial results for the quarter ended March 31, 2021. A copy of the press release is furnished herewith as Exhibit 99.1.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I<span style="font-weight:bold;">tem 7.01 Regulation FD Disclosure.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:7.03%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls, the Company&#8217;s website (www.athira.com), its investor relations website (investors.athira.com), and its news site (investors.athira.com/news-and-events/press-releases). The Company uses these channels, as well as social media, including its Twitter account (&#64;athirapharma), LinkedIn account (www.linkedin.com/company/athirapharma), and Facebook page (www.facebook.com/athirapharmainc), to communicate with investors and the public about the Company, its product candidates, and other matters. Therefore, the Company encourages investors, the media, and others interested in the Company to review the information it makes public in these locations, as such information could be deemed to be material information.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.01 Financial Statements and Exhibits.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(d) Exhibits.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:3pt;padding-Right:2pt;width:9%; border-bottom:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit&#160;No.</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:1%; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:2pt;width:90%; border-bottom:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:3pt;padding-Right:2pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:90%; border-top:solid 1pt #000000;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="atha-ex991_67.htm"><span style="text-decoration:underline;">Athira Pharma, Inc. press release dated May 13, 2021</span></a></p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:3pt;padding-Right:2pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:90%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:3pt;padding-Right:2pt;width:9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:90%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (formatted as Inline XBRL)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:7.03%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information furnished in this Current Report under Items 2.02 and 7.01 and the exhibit attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</p>
<p style="margin-bottom:7pt;margin-top:12pt;text-indent:7.03%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:3pt;padding-Right:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:3pt;padding-Right:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Athira Pharma, Inc.</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:3pt;width:5%; border-bottom:solid 1pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:3pt;width:45%; border-bottom:solid 1pt transparent;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 13, 2021</p></td>
<td valign="top" style="padding-left:3pt;padding-Right:2pt;width:5%; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:2pt;width:45%; border-bottom:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Leen Kawas</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:3pt;padding-Right:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:3pt;padding-Right:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:2pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leen Kawas</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:3pt;padding-Right:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:3pt;padding-Right:0pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:0pt;width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:3pt;padding-Right:2pt;width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="line-height:2pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>atha-ex991_67.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
atha-ex991_67.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="guldvxr03kmp000001.jpg" title="" alt="" style="width:138px;height:69px;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Arial;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">-Phase 2 trial initiation for Parkinson&#8217;s disease dementia program and IND submission for neuropsychiatric program planned by end of 2021-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-style:italic;font-family:Arial;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">-Hosted educational webinar on targeting HGF/MET featuring&#160;leading neurologist Marwan Sabbagh, M.D-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-style:italic;font-family:Arial;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">-<font style="color:#0A0A0A;"> </font>Raised $103.5M in follow-on public offering during first quarter of 2021 - </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">BOTHELL, WASHINGTON, May 13, 2021 &#8212;&#160;<font style="text-decoration:underline;">Athira Pharma, Inc.</font>&#160;(NASDAQ: ATHA) (&#8220;<font style="font-weight:bold;">Athira</font>&#8220;), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today reported financial results for the quarter ended March 31, 2021 and provided recent business highlights.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;We continue to execute on our corporate and clinical goals during this very important time in Athira&#8217;s history,&#8221; said Leen Kawas, Ph.D., President and Chief Executive Officer at Athira. &#8220;Our clinical trials, ACT-AD and LIFT-AD, are actively enrolling and will evaluate the clinical utility of ATH-1017 to treat Alzheimer&#8217;s disease and improve cognitive health.<font style="font-size:11pt;font-family:Calibri;"> </font>In addition to developing ATH-1017 in Alzheimer&#8217;s disease, we plan to evaluate it in Parkinson&#8217;s disease dementia. We also remain committed to advancing our expanding pipeline of novel, small molecule compounds. We have a well-defined strategic plan ahead of us and are well-funded to reach multiple clinical and regulatory milestones.&#8221; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Business Highlights and Anticipated Milestones</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Arial;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">Pipeline</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">ATH-1017:&#160;<font style="font-weight:normal;">A small molecule therapeutic specifically designed to enhance the activity of hepatocyte growth factor (HGF) and its receptor, MET, which are expressed in normal central nervous system function, in order to impact neurodegeneration and regenerate brain tissue.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:12pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><a name="_Hlk71121481"></a><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">ACT-AD trial is actively recruiting and is anticipated to report top-line data by early 2022:&#160;</font><font style="font-family:Arial;color:#000000;">Enrollment is proceeding for the randomized, placebo-controlled Phase 2 clinical trial evaluating ATH-1017, a once-daily investigational drug for the treatment of mild-to-moderate Alzheimer&#8217;s disease. The trial plans to enroll approximately 75 patients in the United States and Australia. Over a treatment </font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="font-family:Arial;color:#000000;">course of 26 weeks, participants will be evaluated for improvement in cognition, global and functional assessments comparing treatment arms to placebo. ACT-AD will also use electroencephalogram (EEG) to measure quantitative electroencephalogram (</font><font style="font-family:Arial;color:#000000;">qEEG</font><font style="font-family:Arial;color:#000000;"><a name="_Hlk71121481"></a>) and Event-Related-Potential (ERP P300), a functional measure of working memory processing speed and executive function. </font><font style="font-family:Arial;color:#000000;">Results from the ACT-AD trial will inform the clinical development strategy for any additional trials of ATH-1017. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:12pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">LIFT-AD trial is actively recruiting and is anticipated to report top-line data by the end of 2022: </font><font style="font-family:Arial;color:#000000;">Enrollment is proceeding for the randomized, double-blind, placebo-controlled Phase 2/3 clinical trial evaluating the safety, efficacy and tolerability of ATH-1017 in individuals with mild-to-moderate Alzheimer&#8217;s disease. The trial plans to enroll approximately 300 patients. Over a treatment course of 26 weeks, participants will be randomized across two dose groups and one placebo group. Clinical efficacy will be measured by improvement in cognition and global/functional assessments comparing treatment arms to placebo. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:12pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">Phase 2 Parkinson&#8217;s disease dementia trial on track to initiate at the end of 2021.&#160;</font><font style="font-family:Arial;color:#000000;"> Athira plans to initiate a Phase 2 trial of ATH-1017 in patients with Parkinson&#8217;s disease dementia by the end of 2021.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">ATH-1019/1020:&#160;<font style="font-weight:normal;">Novel, small molecule compounds designed to be orally available once-daily treatments, to activate the HGF/MET system and to distribute to the central nervous system as potential candidates for neuropsychiatric indications, including depression, anxiety and potentially schizophrenia.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:12pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">IND filing expected by end of 2021.&#160;</font><font style="font-family:Arial;color:#000000;">IND-enabling studies are proceeding for ATH-1019 and ATH&#8209;1020. Athira is targeting an IND submission to the FDA by the end of 2021. Late-stage non-clinical development work and potentially early clinical studies will support decisions on selection of the lead product candidate and indication moving forward.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#231F20;font-family:Arial;font-size:12pt;font-weight:normal;text-transform:none;font-variant: normal;">Corporate</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:12pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-family:Arial;color:#000000;">In April 2021, Athira hosted an educational webinar on targeting HGF/MET, a naturally occurring, neuronal repair pathway.&#160;The webinar featured a presentation by Marwan Sabbagh, M.D., a board-certified neurologist and geriatric neurologist and leading expert in Alzheimer&#8217;s disease and dementia. Dr. Sabbagh discussed the current treatment landscape of Alzheimer's disease and dementia; the need for differentiated approaches; and the critical role of the HGF/MET repair pathway, in mediating brain health and function. An archived replay of the webinar is available on the company website and can be accessed from the investors&#8217; section of the Athira website at&#160;</font><font style="font-family:Arial;text-decoration:underline;color:#000000;">https://investors.athira.com/news-and-events/events-and-presentations</font><font style="font-family:Arial;color:#000000;">.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">First Quarter 2021 Financial Results</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#0A0A0A;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#0A0A0A;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#0A0A0A;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#0A0A0A;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">Cash Position</font><font style="font-family:Arial;color:#000000;">.</font><font style="font-weight:bold;font-family:Arial;color:#000000;">&#160;</font><font style="Background-color:#FFFFFF;font-family:Arial;">Cash, cash equivalents and marketable securities were $357.7 million as of March 31, 2021 compared to $268.2 million as of December 31, 2020. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:11.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#0A0A0A;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#0A0A0A;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#0A0A0A;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#0A0A0A;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-family:Arial;">In the first quarter of 2021, Athira successfully completed a follow-on public offering and raised total gross proceeds of $103.5 million. </font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">Research and Development (R&amp;D) Expenses</font><font style="font-family:Arial;color:#000000;">. </font><font style="Background-color:#FFFFFF;color:#0A0A0A;font-family:Arial;">R&amp;D expenses were $7.4 million for the quarter ended March 31, 2021 and $0.6 million for the same quarter in 2020.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">General and Administrative (G&amp;A) Expenses. </font><font style="font-family:Arial;color:#000000;"> </font><font style="Background-color:#FFFFFF;color:#0A0A0A;font-family:Arial;">G&amp;A expenses were $3.3 million for the quarter ended March 31, 2021, compared to $0.7 million for the same quarter in 2020.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#FFFFFF;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><font style="Background-color:#FFFFFF;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-weight:bold;font-family:Arial;color:#000000;">Net Loss</font><font style="font-family:Arial;color:#000000;">.&#160;</font><font style="Background-color:#FFFFFF;color:#0A0A0A;font-family:Arial;font-weight:bold;">&#160;</font><font style="Background-color:#FFFFFF;color:#0A0A0A;font-family:Arial;">Net loss was $8.9 million, or a net loss of $0.25 per share basic and diluted, for the quarter ended March 31, 2021 compared to $1.8 million, or a net loss of $0.48 per share basic and diluted, for the same quarter in 2020.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">About Athira Pharma, Inc.<br /><font style="font-weight:normal;">Athira, headquartered in the Seattle area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. We aim to provide rapid cognitive improvement and alter the course of neurological diseases with our novel mechanism of action. Athira is currently advancing its lead therapeutic candidate, ATH-1017, a novel small molecule for Alzheimer&#8217;s and Parkinson&#8217;s dementia. For more information, visit&#160;</font><font style="text-decoration:underline;font-weight:normal;">www.athira.com</font><font style="font-weight:normal;">. You can also follow Athira on&#160;</font><font style="text-decoration:underline;font-weight:normal;">Facebook</font><font style="font-weight:normal;">,&#160;</font><font style="text-decoration:underline;font-weight:normal;">LinkedIn</font><font style="font-weight:normal;">&#160;and&#160;@athirapharma on&#160;</font><font style="text-decoration:underline;font-weight:normal;">Twitter</font><font style="font-weight:normal;">&#160;and&#160;</font><font style="text-decoration:underline;font-weight:normal;">Instagram</font><font style="font-weight:normal;">.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Forward-Looking Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This release contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not based on historical fact and include statements regarding ATH-1017 as a potential treatment for Alzheimer&#8217;s disease and other dementias; Athira&#8217;s platform technology and potential therapies; future development plans; clinical and regulatory objectives and the timing thereof, including the timing of the ACT-AD and LIFT-AD clinical trials and filing of INDs for the initiation of trials in PDD and a neuropsychiatric indication; anticipated design of planned clinical trials; expectations regarding the potential efficacy and commercial potential of Athira&#8217;s product candidates, including ATH-1017 and ATH-1019/1020; the anticipated presentation of data; the results of Athira&#8217;s research and development efforts; and Athira&#8217;s ability to advance its product candidates into later stages of development. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words and phrases such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;pursue,&#8221; &#8220;continue,&#8221; and other similar expressions, among others. Any forward-looking statements are based on management&#8217;s current expectations of future events and are subject to </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a number of</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the preliminary data for </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ATH-1017 product candidate from the Phase 1a/b trials will not continue or persist; cessation or delay of any of the ongoing clinical trials and/or </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> development of ATH-1017 may occur; future potential regulatory milestones of ATH-1017, including those related to current and planned clinical studies may be insufficient to support regulatory submissions or approval; the impact of the COVID-19 pandemic on </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> business, research and clinical development plans and timelines and results of operations, including impact on </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> clinical trial sites and contractors who act for or on </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> behalf, may be more severe and more prolonged than currently anticipated, clinical trials may not demonstrate safety and efficacy of any of </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> product candidates; </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> assumptions regarding its planned expenditures and sufficiency of its cash, cash equivalents and investments to fund operations may be incorrect; </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> research and development efforts and its ability to advance product candidates into later stages of development may fail; any one or more of </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> product candidates may not be successfully developed, approved or commercialized; adverse conditions in the general domestic and global economic markets; regulatory uncertainty as a result of the new U.S. administration; regulatory agencies may be delayed in reviewing, commenting on or approving any of </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> clinical development plans as a result of the COVID-19 pandemic, which could further delay development timelines; the impact of competition; the impact of expanded product development and clinical activities on operating expenses; impact of new or changing laws and regulations; as well as the other risks detailed in </font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Athira&#8217;s</font><font style="font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof and Athira undertakes no obligation to update forward-looking statements. Athira may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements, and you should not place undue reliance on the forward-looking statements.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk71640221"></a>Investor &amp; Media Contact<font style="font-weight:normal;">:<br />Julie Rathbun<br /><a name="_Hlk71640221"></a></font><font style="text-decoration:underline;font-weight:normal;">Julie.rathbun@athira.com</font><font style="font-weight:normal;"><br />206-769-9219</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Athira Pharma, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="CONDENSED_CONSOLIDATED_BALANCE_SHEETS"></a><a name="CONDENSED_CONSOLIDATED_BALANCE_SHEETS"></a>Condensed Consolidated Balance Sheets</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Amounts in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">March 31,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Cash and cash equivalents</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127,823</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60,625</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Short-term investments</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">176,367</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124,057</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Other short-term assets</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,378</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,655</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Long-term investments</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,467</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83,509</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Other long-term assets</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,379</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,717</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">369,414</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">279,563</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Liabilities stockholders' equity</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Current liabilities</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,497</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,405</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Long-term liabilities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,700</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">876</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,197</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,281</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders' equity</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">363,217</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274,282</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders' equity</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">369,414</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">279,563</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU2"></a>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Athira Pharma, Inc.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;"><a name="CONDENSED_CONSOLIDATED_STATEMENTS_COMPRE"></a><font style="Background-color:#FFFFFF;"><a name="CONDENSED_CONSOLIDATED_STATEMENTS_COMPRE"></a>Condensed Consolidated Statements of Comprehensive Loss</font> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Amounts in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March 31,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Helvetica;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,445</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">592</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,336</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">675</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,781</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,267</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,781</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,267</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grant income</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,831</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense), net</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(560</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,866</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,805</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unrealized (loss) on available-for-sale securities</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive loss attributable to common shareholders</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,871</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,805</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share attributable to common stockholders,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; basic and diluted</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.25</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.48</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net loss per</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; share attributable to common stockholders, basic</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; and diluted</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,775,454</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,747,356</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Helvetica;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>guldvxr03kmp000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 guldvxr03kmp000001.jpg
M_]C_X  02D9)1@ ! @$ 8P!C  #_[@ .061O8F4 9      !_^$ 2D5X:68
M $U- "H    (  ,!&@ %     0   #(!&P %     0   #H!*  #     0 "
M         &*W/P !    8K<_  $  /_B#%A)0T-?4%)/1DE,10 ! 0  #$A,
M:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$  &%C<W!-4T94     $E%
M0R!S4D="                  #VU@ !     -,M2% @(
M                                                $6-P<G0   %0
M    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($    %')865H
M  (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4    <&1M
M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D   /X
M%&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=44D,   0\
M   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE
M=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="($E%0S8Q
M.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M                                                      !865H@
M        \U$  0    $6S%A96B                      6%E:(
M &^B   X]0   Y!865H@        8ID  +>%   8VEA96B         DH
M#X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M       6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                     &1E<V,         +DE%0R V
M,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M        +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E
M("T@<U)'0@                            !D97-C         "Q2969E
M<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M       L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V
M+3(N,0                                  =FEE=P      $Z3^ !1?
M+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7'^=M96%S
M          $                        "CP    )S:6<@     $-25"!C
M=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/
M %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X L@"W +P
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M$0 _ +_
M
M
M
M
M
M
M
M
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M,28[[2B4A:%*2I)D9&9")RC*$G"::DG@T]#7.9I-26,7BF?K'X?H
M
M
M
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M;A--3BVFGK36M,L>,E)*47C%K%'[A\GZ
M
M
M
M                              %4S]H'V]:VFXM,Z-CREIQ[#\ ?V181
MFU+0U*R7-+RVH(WM:#,D//4]+B1*85P?EIL72(^5*(K>[.;*$+*OF#7TDZFP
MO-BD]'.Y:?-1!]ZKB4KBG;+R(PVNEMKO)=\KV"R"*     %VCT7]O6>UNQC#
MZ^YE/3K'4.69-J$YDA3RWG:RC9J,FQN*:W3-*F:?%\OA0&2;^(AB*A/UR5"B
M-^+*%GG\Y06$:T(U,.5XQEW91;?*RQ]W;B5?+(J6ETY.'0L&NXFET$KPB!G
M
M
M
M                                                          J
M^OIBUK5]W6"92^PKW-E6C\>CUDPD&32Y^/99F4:V@=9^"WXC,Z(\KCP)$I'U
M1='9W6A/)JE%>7"XEBN248X/IP:Z" [T0E&_C-^3*DN\WC^#ND&XGQ&@
M"XEZ"V(6&/\ 9EDV0SX[S+6=[QS"[I7%K=\F72U.,X3BGM#+2C\HC3?T5@TI
M:2Y4;1),SZ"(J4[0JT:F>0IQ>FG;Q3Y&Y2EX&GTE@;KTW#+I3?OJK:YDDO"F
M3:""$C
M
M
M
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MGF%[5S*]JWU?ZRK-OF7 ER)8)<B+4M;>%I;PMZ?D0CAS\;Z7I,MCIG.
M
M
M
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MCEUKE]/8MUXSUR>F3YW^!:#:\8<[P
M
M
M
M
M
M
M
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M3P333C)1G&45[\2<C
M
M
M
M                   'DL]S&KU]A659O<K)-;BU%97<E)K2A3Y0(KCS4-DU
M>!R9SZ4LM)^%3CB2+Q,8/>7/K/=?=Z]WBOWA:65M4K2TX;6Q%M17XTWA&*X9
M-):S.;LY#>;T;PV6[N7K&[O;FG1CHQV=N23D_P 6"QG)\$4V]15>R?(K3+LC
MO<IO)"I=QD5O875G(4:C-V;92G9<@T]1J-+9..F24\\)21$7@0\8<XS6]SW-
M;G.<QFYW]W7G5J2XYU).4NC%Z%P+!'M%D^566193;9+ET5"PM*$*5./%"G%1
MCTX+2^%XL^$,<9(F)]+*5:+I=SPG5OG2Q[3!Y5>VK_X9%I,B90U;K:/X//<B
M08).?^JE WR]C*M>2R_>"WFY?9\:UG*"]ZJDHW"JM<KC"CM<BB:%^V?1LXYA
MN_<04?M"5&\C-^^=.,K=TD^12G6V>5R)8ANR:1@
M
M
M
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M/GX\)Y>^U-O$\[[5:V7PEC;99:T;=8:MIQZ^H^=2J[$O,PX#>4;&FN(
M
M
M
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M>2C1IQ<I-ZE&*Q;?(DL2UGKW$X^"8'AN%Q>@V<4QBCQ]*T%PEY=56QH3L@_
MC4N2ZRIQ2C\5*49GXF/:G=?)*6[>[5AN_1PZNRLZ-'%</5TXP<N>33DWPMXG
MBCO3G=7>7>7,-X:V/67MY6KX/@ZRI*:CS1344N!+ ]@,\8$
M
M
M
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M1)O4BS$/7<\A
M
M
M
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MV].6TN;K*U)\Z1-\/1(\Z@
M
M
M
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M@YSZ7OUE^2P>-.SRY3?)4KU9N2^13I/I)*!ML:C@
M
M
M
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MD>2';[F_VSVO9W<)XPI7*MUQ+T>G"A)?+IR;Y6S9P7 4\
M
M
M
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M*;QPX?&/1#*F*
M
M
M
M           ""[U$MY?+G8D;55%-)[&=;O.'<^0OJ9GYR^VMF<2S(S2OY.0W
M#B)^!3<AR4D^?#CSA]JGM&^\>]4-RLMJ;63Y3)];@]$[QIJ>/'U$'U2X8SE6
M3X#TA]E3LX^[FZL]]<RI[.<9M%=5BM,+--.&'%U\UUKX)0C1:X2.4:I&UX
M 95T90%E.Y]4X^MOS6+386(QYB.%*+W?[\A.6*C2DTJ-+<%MQ1\&7@7PE\(F
MG9QEGVSO_DN5R6U3K9I;1DOQ.N@YZN*"D]:YT0OM(S3[%[/\[S2+V:E'*[J4
M7^/U,U#7QS<5J?,]1:6'LN>,8
M
M
M
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MK)Y1
M
M
M
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M\ESTK\)JK[7M_*V[-;6S@]-QF])/S84;B;_*4-#_  $[(](SS9
M
M
M
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MD&7_ *2O=U.#_EQH1Y_^;HT8/3Q:9BQOF:%
M
M                         '^*4E*34HR2E)&I2E&1)2DBY,S,_ B(@!%S
MW$^K]V:]OUG/QEK*[;<&8UKJHTZBU'$@Y!7UTI*EMN,6.7S[*JQ(G8SK:D/M
M19DR3'672XRE7@)9EFY>=YE!57!4:#U.HVF^:*3ES8I)\#,+=Y_E]K)PVG4J
M+@AI[^*7<;9HK_S#FOO;O+_LR9E[M\_I]K_"/2>W>S=7'G>[_DM[/Y_1X^7[
M5T\^'7]42#^VUSLX^EPV^+8>'=VOP&,^]E+'ZF6SYR]S\)O5V[>K]V:]P-G
MQEW*[;3^8V3J8T&BVY$@X_7V,I2D-ML5V7P+*UQ(W9+KB4,-2ID.3(6?2VRI
M7@(_F>Y>=Y;!U5!5J"UNFVVN>+2ESX)I<+,G:9_E]U)0VG3J/@GH[^+7=:9*
M,E25))23)25$2DJ29&E23+DC(R\#(R$3,T?Z
M
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MBL-3//SVR[I3WDR6QQ6-.QK3PP>/TE51UZM/5:%K6#QUHE)&Y1ID
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MC@']N,T_3V_Y?YH^]5G^CJ_D^Z/^8*[:OY%MY?\ 1X#_ !P#^W&:?I[?\O\
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M6U4BM4H\,TOA+7+C6+UK3+,@SB<*D;&Y>-*6B#? ^"/,]2XGHU:K5@J(FX
M
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MZ>&/,]:Y"VJ%:->C&O#R)Q372L3WHZYR@
M          !'GZK?ZOGN4^;.+_2)AXDNZ']26OG2^9(Q.>>JJWFKYR*(HV!*
MR     +,?[.M_?"_R^_TW"K.TO\ @OVW^43+=+^(^)_C+,8JPF(
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M-+BSCY%.K)+S<<8_DX%KV-=W-G2KORI03?/P]_$V#&-.V
M
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MC9K&^@L*=Q#3Y\,$^['9?*\2?;L776V4K>3\>E+1YLM*[^/>)Q! B2@
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M]],M#)H.&5T4]>QCW6VN\S>\1XR8
M
M                 !CK:^S\9T]@E[GV5OFW6TT?EF*TI)3+:R>Y17T]>A7@
MN9/D<)3_ *J$]3B^$(4913?7?#*-P]V[G>;.Y86EO'1%8;56H]$*4$]<YRT+
M@2QE+",6U*]R=SLXW\WEMMV,DCC>7$M,GCLTJ:TSJS:U0A'2^%O",<922=9S
M:NS,EV_GE_G^5R/-M+R4:VXS:E'$JJYDO*KJ>O0KCRX5=%2EM/AU.&1N+-3B
MUJ/R(WTWOS??K>6ZWGSJ6-Y<SQ45Y-.FM%.E!<$*<<(KA;QE+&4I-^O>Y6Z&
M4;B;M6N[&2QPL[:&#D_*J5'IJ59OAG4EC)\"6$8X1C%+'@BQ*CT&*8O>9MDE
M)B6-07+*^R&RC557":X(WI4IPFT&M:N$,L-$9K=<49(:;2I:C))&8RF2Y-F.
M\.;6^1Y13=;,KJK&G3@N&4G@L7J45KE)Z(Q3DVDFS%YWG.7;O91<9YF]14<L
MM:4JE2;X(Q6+P6MR>J,5IE)J*3;2+,';]I:DT/K2EP:K\B38(3[QRFZ:;-"K
M[)9;;96$\^HB<**T3:6(R%>+<5ELE<JZE'ZZ]F'9_EW9KNC;[N66S.Z2ZRXJ
MI8==<22VY\>RL%"FGI5.,4\7BWY#=J':#F/:7O?<;QWNU"U;ZNWI-X]3;Q;V
M(:-&T\7.HUH=24FL%@EFL6$5X:[=VKCC7;;N)32UMJ/#IC9J0I2%&V\_&:=0
M9I,C-#K2U)47P*29D?@8JOMOE*'9+GS@VGZ!-:-&AN*:YFFT^-/ M7L.A&?:
MWD*FDUZ?!Z=.E*33YTTFN)K$K.CR(/7L "Q%V"Q5Q^UK7SJE)4F=.S24V2>>
M4(1FM_"-*^2(NHW(:C\.2X,OJCU0]F6C*EV-97-M85*EW)<B5W6AIZ8M\V!Y
M6>TY6C5[9LT@D\:=.TB^5NTHST=$DN?$W)%]E!
M:5>H;OW^S=V@;FV-"FJA91(QMW"L%<9<\N8C,\W/Y.T\^$9_%4_CR9KMJ9&9
M<M05\<GP1YW=O+OM3.J%M)8TE+:GQ;,?&:?/AL])CLVNO0["I63PGAA'G>A=
MS7T% X;$E6@      2C>C]OXM&=ZV!5]E,*+BFYX\G3V0>8I1LHG9-(B2<)D
MI;X-LI'RXKJ^+YI]/E1I;Q\\&HCB6^F7?:&15)16-:@^L7-'':_(;?.D9O(+
MKT;,8I^14\1].KOX+I9> %#%D
M   !'GZK?ZOGN4^;.+_2)AXDNZ']26OG2^9(Q.>>JJWFKYR*(HV!*R     +
M,?[.M_?"_P OO]-PJSM+_@OVW^43+=+^(^)_C+,8JPF(
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M1]D?!]
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M1I:(S2D_ M;,WL)99F5:QECA3FTN6+TQ?3%IEL6-RKRTIW*]]%8\^IKH>)L
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M34?E2>M^XN)>%FZ(P9D0
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M1L"5D     68_P!G6_OA?Y??Z;A5G:7_  7[;_*)ENE_$?$_QEF,583$
M
M                                          "'7U2H=O[[T_8+)Q5#
M[JRV'&425&RQ;^UTCTXEJ)'2VY+A^S]!&KE9,JX+XIF-#?;+H7WVAD5U+%Y;
MU-S&/$JNU1<\=&ARAL88O3L/!:&;Z^QE7L?L[/K6."S/KK:4N-TMFLH8:=*C
M/;QP6C;6+\9$3PTF-VP             _JR\]'<0\PZXP\V?4VZRM3;B%?\
MI(<0:5)/_21C[IU)TIJI2DXU%J:>#7,UI/BI3IU8.G5BI4WK36*?.GH,G46\
M=S8ST%0[6V'5M-\<1HV87Q0C(C<4DG(*YRX;J4J=49$ILR(U&?PF8F&6]HV_
M^48?9F=9K1@O>QNJVQPZX.;@];UIZ6R'YEV<]G^<8_:>2956F_?2M:.WP:IJ
M"FM2U-:D9KH.^WN>H4H:/82+N.V7!,7^-XW/4?Q>GE<Y%5'M'#\"/XSY^/C]
M4^;"RSVDNV'+4H/-%<4EP5J%"?=FJ<:CZ9_A*\S/V;.QW,VYK*G;U7PT:]>'
M<@ZDJ:Z(?@PSC0>IYMF&:$Y)@> WC22X-57[^H)3GUO"ENO6EY&ZOKN>EA)>
M)>'@?-BY9[8>^]!I9MEF67,%^CZZC)\[=2M'CU07!HT::YS/V.MR*Z;RC,\S
MMIO])U->*YDJ=&7%KF^'3IT9RQ[U1L&DF@LLU9EE,7'QU8]=4^2F2N2+XB+)
MK$^2-/)^*BX/P\?A%C95[9&[E7#[;R6]M^/J*M*X[BJ*V\/)RE<9K[&F\=+'
M[$SJQN'P=?2JV_==-W/@]PSOCOJ =LMZ22EY;<8N\LCZ6,BQ:[(^2\>E4BCC
M7<%LS+G@U.D7AQSR9$=DY5[3W9!F22KWU>SJ/@KV]7ORHQK073)+IP*US7V8
M.V#+6W0L;>\IKAH7-'O1K2HS?1%OHQ,]XWOC2V7J;;QS:N VDEY70W!:RFG9
MLUJZ241%5R93%CP9'X'Y7!F1E\)'Q9F4]I79]GK4,ISK+*U63P4%<4E4?[.4
ME/\ )X^)E9YMV:]H.1)SS;)<SHTHK%S=O5=-?M(Q</RN+C1E@38A       $
M=??#W9IU74R-6Z_L>-D7T+BYM8;JTNX12S&DFAUIYLTFUD=JPY^]B2?7%9Y?
M/I4I@U:J^T5VW+<NQGN9NO5__P!LN:?TM2+>-I2DM#36JO43^CP>-./TCP;I
MX[5^SIV(/?2^AOGO12__ -2MJGT5.26%W5B]*:>NA3:^DQ6%27T:Q2J804F9
MF9F9F9F9F9F?)F9^)F9GXF9F/-YO'2]9Z2I)+!:C_ !G/M\T7DF_MA5^'TQ.
MPZE@VY^69#Y7F1\?H4.I2_)/JX;>L91_8HC')&\\?)]+:'%HL;LN[.,V[3=Z
M:60Y?M4[&.$[FOAC&A13\:7$YR\FE#WTWIPA&<HUQVI=I&4]F.ZU7/LPV:E]
M+&%M0QPE7K->+'C4(^55G[V"T8SE",K)^$X9CFO,4H\+Q*N;J\?QZ U7UT-O
MXRB;1RMV1(=/X\F;,?6MY]Y?*WGEJ6HS4HS'K9N]D&5;K9+;;OY)25'*[6FH
M4XKB6ERD]<IRDW*<GIE)N3TMGD?O#O!FV].=7.\&>576S2ZJN=23XWH48K5&
M$8I1A%:(Q2BM"1ZD9DPP   :M]ZGYK^VO_M%/]]5"*:]H+_\=SS]12_^Q1+F
M]GO_ /9,C_7U?_K5BMP/)D]:@ +(_97^:_J7_P"T7'WU7P]9O9]__'<C_45?
M_L5CR5]H3_\ 9,\_7TO_ *U$VD%RE,@                   $87J\;^_ 3
MV4["C5LXHF6;B<8T]C:4.-E)*-E4>6YF4M+1\ODRS@\&P9\Y!%Y,F2Q\8E*3
MS*]S,N^T,]IN2QHT/I)?%PV5\IIX<*3,+GUUZ+ETTGX]3Q%TZ^]CWBD71TEK
MDMU3XY107K.[O[2OI*:MCDDY%A:VLMF#706"6I"#>ERWT-IY,BZE%R9"^*E2
M%*G*K4>%.*;;XDM+?<*XC&4Y*$5C)O!<[.B+VX:;JNWS1&J=+TY,*C:\PNFH
M9DJ,V335I>H8]KR:[\M*4$EV^R.5*FN>!&;CYF?B-:\SOIYEF%:^GCC5J-KD
M7O5T1P706Q9V\;2UIV\=4(I=/"^EXLU*]5_07X?NRC:$&!"5,RO633&X,12T
MCS'O;L)8F.Y!&::3PZ^[881-M6&FTGRJ0XV?"C223S&Y^8_9V>TI2>%&K]'+
MFEAAW)*+YL3HY[:^E9=-+RX>.NC7WL2BT+_*S     -W_3FWXGMQ[P]-Y]/G
M% Q:RR!O \Y>=428C>(9STT%C/G'U)/V3'Y<J/:*XY/J@EP2OK3P&\V7?:>2
M5[>*QK*.W#SH:4ESZ8])DLINO0\PIU6\(-[,N9Z.]KZ"_.->"T0
M    YK^:?=CEGSFOOMI*&T-#ZF'FKP%/U/K)><_">9'*?    29>CQ^L:[=O
MRN?05LX17?7^F;G]G^]IF9W?];T?C?,D7E!0990             1Y^JW^KY
M[E/FSB_TB8>)+NA_4EKYTOF2,3GGJJMYJ^<BB*-@2L@    "S'^SK?WPO\OO
M]-PJSM+_ (+]M_E$RW2_B/B?XRS&*L)B
M
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MQ@3)            <U_-/NQRSYS7WVTE#:&A]3#S5X"GZGUDO.?A/,CE/@
M ),O1X_6-=NWY7/H*V<(KOK_ $S<_L_WM,S.[_K>C\;YDB\H*#+*
M     "//U6_U?/<I\V<7^D3#Q)=T/ZDM?.E\R1B<\]55O-7SD411L"5D
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MQHPM?>F-N&%YB\>S77UZT@SZ6YK]]1S72ZDI3T,E3VD,E=)\J)4A)$1>!F?
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MM@  !'GZK?ZOGN4^;.+_ $B8>)+NA_4EKYTOF2,3GGJJMYJ^<BB*-@2L@
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M'<2MMQ"E(6A1*29D9&*PE&4).$TU)/!IZ&FN!DO34DI1>,6?K'X?H
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MJ49F*:N;JXO*SN+J<JE:6MR>+_\ YQ+4N GE*C2H05*C%1IK@6@]L. Y
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M&W;C'#4Y:I2Y<6L%^*DUK98^0Y>K*T52:_\ 8J)-\BX(_A?*^0E<$0,X
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M#'@QQU\!W\KNO0<SMKW'#J:].>.&.&Q-2QPX<,-7"5+!XA'N" !--Z75B3N
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MA56G\6?BO\K8)+NO<.G>RH/R:D._'2N]B6^Q3!/@
M           ,.;=T+J[>%45;G^-QYTIAI;59D,+I@9+3=?)\UMPVVIY+1+^,
M;#I/17%$1K:5P0@6_/9IN;VBV7HF\]I&I6C%JG7AXEQ2Q_1U4L<,=+A+:IR>
M#E!X$]W%[3-\NSJ]]+W8NY4Z,I)U*$_'MZN'Z2DWACAH4X[-2*Q49QQ(:=]]
MA&SM5E-R#"2?V7A+/F/K=JX:BRNFC$I2O_FM"QYJYS$=HRZI4(W"X2IQQIA!
M#0;M,]F??#<OK,TW>VLWW>CBVZ<?_9I1_P"I16+FHK74I;2T.4X4HHW][,O:
M9W.WT=/*]XMG*-XI8)*I+_UJLO\ IUGAL2D]5.KLO2HPG5DS0XR,C,C(R,C,
MC(RX,C+P,C(_$C(QK4UAH>LV6336*U'^   -E=$=U6U-"2VH^/V?OS#UOD[8
M8/>NO2*5TEKZI#U4LE'(H;!U)G]ECF3:U\*>:>)))%M]FW;1OIV9UXTLKK>D
M9"Y8SM*S<J3Q?C.F_*HS>GQH:&\'4A422*C[2NQ7<OM-H2JYI1]&SY1PA>44
MHU5@O%51>36@M'BSTI8JG.FVV;G;G]21=[A$"HT]1VN,93=P5ED=Y=^R/.8L
M:TJ9=A8UY"G&[*<Z9FI$]U#),M])I9\U?+%_[_\ M:2S+=VE8[AVU>SSFXIO
MKZU;9;M\=#A;X8JI-ZU6DHJ$<&J>W+Z/7[L_]DF.6[Q5;[?RYH7F2V]1=11H
M[25SAI4[C'!TX+4Z,7)SEBG4V(_2122Y<J?*D3ITF1-FS'W9,N9+><DRI4E]
M9N/2)$AY2W7WWG%&I2U&:E*/DSY&E5>O6N:T[BYG*I<5).4I2;E*4F\7*4GB
MVV]+;>+>EF[%"A0MJ,+:VA&G;TXJ,8Q2C&,4L%&,5@DDM"26"6A'YQQ'*?K@
M0)UI.AUE9#DV%C826(4"!"8=E3)LR4ZEF-%BQF4K>?D/O+)*$)(U*49$1<CG
MMK:XO+BG:6E.=6ZJS4(0@G*4Y2>$8QBL7*4FTDDFVW@C@N;FWLK>I>7E2%*T
MI0<YSFU&,(Q6,I2D\%&,4FVV\$M+)QNS_LHA:L37;*VC$8L-D\*D4U$I;$RK
MPE+A)\F0I2"<9G9.E')F\E2F8G5PUU.)\X>B_83[/=ON8J6]N^4(U=[<-JE1
MQC*G:8ZI:,5.XP]\FXT\<(8R6V><O;O[0UQOFZNZ.YLY4MT<=FK6PE&I=X:X
MZ<'"WQ]XTI5,,9X1>P2-#:TU0               *G&8U9TF7952F@FSJ,CO
M*LVR9*.2#@6<J)T%'(U$P2?*XZ",^GX/J#Q*SZS^SL]O<OPPZB[K4\,-G#8J
M2CAL\&K5P:CVZR&\^T<BLLPQQZ^THU,<=K';IQECM<.O7PZSS8Q)EB6KTLK3
MHG[HI%+Y]HAX-:,(-WCH]B>RF)*6ACI/J\SV]DEKY+CH27!\EQN][&5YLW6\
M&7M^73LZB6.K8=Q&32Y=N.+X,$M..C1[VS[+:M=W\P2\BI>4V\->VK:44WR;
M$L%PXMZ,-,P(WM-$                 *^GK\[]/&=0ZP[=J>?Y=EL_(7LW
MS".P\I+J<.P=;2*2#/9(R2N'>9=.1)9,^?LU(?P<%S8_9WEW6WM7,YKQ:4=F
M/G3UM<JBL'R2(KO3=;%O"TB],WB^:.KNOP%='M&T9+[DNY/3VEF&WUPLUS*O
M8R1V,HVWX6&51.WN;6#+G4@D/P<3K)CK7QD]3J4I(R,R%F9SF"RO*Z]\_*IP
M>SRR>B*Z9-$2L+9WEY3MUJE+3S+2^]B=#&'$BU\2+ @QV8D*%'8B0XD=M+,>
M+%C-)9CQV&D$2&F66D$E*2(B2DB(AK;*3DW*3QDWBRUDDE@M2/T#\/T
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MC*7R/'_PF2RBIU>9T)<=1+Y7B_A+]PUW+1
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M+B63Y3UEGN73GC&DVE4N'%XQJ7#3:P36,**;A!X2DYS491W7&PAKT
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M.Y68^GY%3C)XUJ#=-\T=,?R6ESIE;Y_:^C9C)KR*GCKIU]]-])%L):80
M N.^AGOU.SNT^?J:SF)>R70.4R:)ME2C7)7@F9/3LEQ.9(6M9J/R[;WQ ;21
M$EN/ :(O]%)[_9=Z)G"O(+Z*YAC\>.$9+N;+YVRP=VKKKK%T)/QZ4L/BO2N_
MBN@FI$%)$        '-?S3[L<L^<U]]M)0VAH?4P\U> I^I]9+SGX3S(Y3X
M  "3+T>/UC7;M^5SZ"MG"*[Z_P!,W/[/][3,SN_ZWH_&^9(O*"@RR@
M       CS]5O]7SW*?-G%_I$P\27=#^I+7SI?,D8G//55;S5\Y%$4; E9
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M $WL=OZR6,K6O;55_P!^%)O4]4:K;PPP6+QPQ3L,#U*/+(
M U&[[=^%VT]J&YML1991,CK,5D46$+)1^;\N<M<;QO%7VFT*0X\57:V:)KJ4
MJ2KV>*X?)<<EF=W\N^U,XH6;6-)SQEYD?&EW4L%RM'0S.Z]#L:E=:)J."\YZ
M%W'IZ#GZ*4:C-2C-2E&:E*49F:C,^3,S/Q,S,;&%5E_CT^]!'VU]HNFM9S8)
M0<H+&FLMSM"XZ6)99MFBU9'>PIYER;\G'W)Z*M+A^)L0&RX(B(BUVWCS'[4S
MFO=1>-+;V8<6S'Q4USX;7.V6EE5KZ'84Z+6$]G&7.]+[FKH-S!@S(@
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MI6MM6E!ZGLM1?QI8+OG2KYE86[PK58*7%CB^XL7WC2#+O7'[$<;6\BFN=H[
M2UYO0YB.NI4)$CRS62/)+/;+"'$^>2"-'F)1P2BZND^2+/4=P=X*OEQHT_.G
MC\Q2,;4WERR'DN<^:/YV!@RV_:#.W%DGO<6DMV6)I>Z8_O96"4I.Q^H_LKQP
M\HO_ "'NGQ\M/F)Y\.OZHR$.SC,W]97H+FVWX8HZLMZK3WM.H^?97X6>?3^T
M*::ZBZNWG9I)Y+J-.3XJI1)Y\3))H22C(OJ<ES^Z.3^V]]_N:7R9'S]Z[?\
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M?,8   &<^V'\Y7MY_'EJ7[_J 8_-?5=S_+U/F,[-E_K*7ZV/SD=%,:TEM
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MFO'45KVQY=]J=EF?VF&+65UZB6O%T8.LL%@].--8<..K#66<Q[!'CR
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M>CQ^L:[=ORN?05LX17?7^F;G]G^]IF9W?];T?C?,D7E!0990
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MQY:E^_Z@&/S7U7<_R]3YC.S9?ZRE^MC\Y'13&M);0
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M(6P\9_9FG#2A2+E[*NVS>KLONE0MI>E[LSGC4M*DFHZ7IG1E@W1J/A:3A/\
MYD)-1<:9[5NQ+=7M1M77N8^A[S0AA2NZ<4Y:%HA7CBE6IK@3:G#_ )<XIR4I
MZM.[OU[O+&D9)@=PB5Y1-(N*.7Y<>_Q^4ZDS*+<5I..+9ZC2HFWD&Y&?Z%&T
MXLDGQZ6[A]HFZW:-E"S;=JNI[."JT981K4)/WM6GBVN'9FG*G/![$I8/#S.W
M][.MZ>SC-WE.\MNX;6+I5HXRH5XKWU*I@D]:VH-1J0Q6W&.*QRX)R08
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M&P)60    !9C_9UO[X7^7W^FX59VE_P7[;_*)ENE_$?$_P 99C%6$Q
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MV8=LFZ7:C9__ /+J>CY[".-6SJ276PU8R@]"K4DWAUD%HQ6W&#DD:WBIRV0
M/:Z_V)F>KLFA9?@E],Q^]@GTID15$IF7&4I"WH%E#=)<2RKI!MI\QAY"VU&D
MCXZDI,I#NQO5G^YN;T\]W;N:EKF5/WT=4HXIN%2+QC4A+!8PFG%X)X8I-1[>
MC=7(-\\GJ9%O);4[K+:GO9:XRTI3IR6$J<XXO"<&I+%K'!M.=_M@[S</WM'A
MXQD)0\1VBACAZC4\:*C)%LHY?EXK(DN*=6LT)-Q<!U2I+*>>E3Z$*=+TF['>
MW[(>TFE3R?->KL=\E'31QPI5VEIE;2DVV\/&=&3=2"QP=2,93/-7MC[ ,^[-
M:M3.,JZR^W,<M%;#&K03>B-S&*22Q\55HI4YO#%4Y2C W7&PAKT
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M];UOB_,B1FB5&&   #TV%_=CB?SFH?MI%'%7^IGYK\!]T_K(^<O"=* :O%P
M    '/2[U/SQ^[3_ (F=\?2GE0V1R+U)9_RM+]W$JG,?6%?]=/YS-9AE3I
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MUG_Z];%PQ][-+%KFDE\I+!:61;>7+XU:'IU-?2PT2Y8OW'WF^)%307"04
M  SGVP_G*]O/X\M2_?\ 4 Q^:^J[G^7J?,9V;+_64OUL?G(Z*8UI+:
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M2P226A)+!(T_K5JUS6E<7$Y5*\Y.4I2;E*4F\6Y-XMMO2VWBV?W'(<0
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M"DF:5)4D^2,O R&[491G%2BTXM8IK4UQHTCE&4).$TU)/!IZ&FN!G_0_3\
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MGP   $F7H\?K&NW;\KGT%;.$5WU_IFY_9_O:9F=W_6]'XWS)%Y04&64
M      !0=]2/<\G>G>IOG+3EN2J:CS.?KO%2,^8S6-Z[<5B4-Z"DS,VXEQ*K
M'['@^%&Y,4HR29FDMA]V+%9?D5O1PPG*"G+SI^,\>;%1Z"K\WN'<YC5J>]4M
ME<T='?U])HV,^8P   /2X9C$W-LPQ3#*TS*QR[):+&(!I9<D&4V^M(M5%,H[
M7V5\R?EI^(GXRO@+Q,<5>K&A1G7EY,(N3YDL3[IP=2I&FM<FEW7@=(?&L>JL
M2QV@Q2ABIA4>,TM5CU-"0221$JJ6"Q6UT5!)2E))CPXR$%P1%P7P#6*K4G6J
MRK5'C4G)MOC;>+[Y;T(1IP5..B,4DN9'VAQGT      !XC9F!4FT]=9YK/)$
M>90; P_(\,N")"7%IKLEJ)=/+=:2HTEY[#,PUMGR1I6DC(R,B,<]K<5+2YIW
M5+ZRG.,ESQ::\!QUJ4:]&5&?DSBT^E8'.(R&CL,8O[S&K9M+5KCUQ9T=FTA1
MK0W85,U^!-;0HTH-2428ZB(S(C,B^ ALW3J1JTXU8>1**:YFL45%.+A)PEY2
M>'</CCD/D   ,Y]L/YRO;S^/+4OW_4 Q^:^J[G^7J?,9V;+_ %E+];'YR.BF
M-:2V@                     -:]N]VFD-,^TP\BRIJXR2.2TGB6*$S>7R7
MD&:5,34M/M5U,Z2B^MFR(ZC+Q21BI-^NV_L[W VZ&:WL:^;1Q_\ 6ML*U;%<
M$\&J=)\E6<'Q)EN;B]A_:+V@;%?*K*5OE,L/_9N<:-'!\,,4ZE5<M&$UQM$5
M^XO41VUGB953K^.QJ['G>6_:JY\[',)+1ETJ\R_=:98K"69$I/L4=E]L^2\]
M9#3#?SVJ-^-Y5.QW7C')LKEHVH/K+J2Y:S25/'6NJA&<=76R1NCN%[*NX^[3
MA?;T2EG.:1T[,UU=K%\E%-NIAJ?6SG"6OJHLT$GV$^UFR;*TG3+*QFO+D3)\
M^2],FRY#A\N/R94A;C[[RS\34M1J/ZIC66ZNKF]N)W=Y4J5KJI)RG.<G*<I/
M6Y2DVY-\+;;-G+6UMK*WA:65.G1M*<5&$(14(1BM2C&*2BEP))(_&. YP /V
M0*^?:S8U;5P9EE8S7D1X<"!&>F39<AP^&V(T6.AQ]]Y9^!)0DU']0ASVMK<W
MMQ"TLZ=2M=5)*,(0BY3E)ZE&,4W)O@239P75U;65O.[O:E.C:4XN4YSDH0C%
M:W*4FE%+A;:1))HGTY\TRPX60;EEO8)CZS;?3B\);$C,K%@R0LDRU\2*_'&W
MD*^!SSY:3)25L-*X4-L^S;V4]X,[=/--_IRRW*W@_1X-.ZFM>$GXT*":^%MU
M5I4J<'I-2>TKVKMW\D53*]P*<<RS18KTB:E&U@]*QBO%G7:?P=BD]#C4FM!+
MWKG5N ZFH6\;U_C-=CM:1-').*V:YUD^TDT)EVUD^IV?:2^%'PX^XLTD?">$
M^ WJW4W-W9W(RQ93NO9TK2TT;6RL9U&EAM5:CQG4E^-.3:U+!:#1/>S?/>;?
M?,WFV]%Y5N[O3L[3PA33>.S2IK"%..KQ812>MXO29 $G(P             &
MA?='V18KN5N?F6")@8CL\R4_(<Z%,8_E[A)Y-J\880HH-JX9?%GM(-2SY)]#
MG*5M:T]LGL[Y+O\ 1JY_NVJ=COCY4GAA0NGQ5DD]BH^"M%-O54C/1*&R_8U[
M16=;@2I9!O*ZE]N=Y,5KKVJXZ+;6W37#1DTEKIRA@XS@OS'#,HP#(K'%,RI)
MV/Y!5.^5-K9[7ENHY+EMYE:34S*B2$<*:>:4MIU!DI"C(R,><6?9!G.[&:U<
MDS^WJ6N:4983IS6#7$T]*E&2TQE%N,EIBVCTAR'/\FWGRJEG>07%.ZRNM'&%
M2#Q3XTUKC*+T2A)*47HDDSS PYF  )#NTWO>N=3N5V ;/D3\@UH9M0ZRTX5,
MNL'0:C2W[/R9R+3'&C477%,U.QFD\QB,D^0YM-V(^T3?[DRI;L;X3J76Z.B-
M.IY=6S6I;/OJE!<-/3*G%8T<<.JEJOVW^SK8;[QJ[S[G0I6N]^F52GY%*\?#
MM>]IUWP5-$:DGA6P;ZV,Y-+=U&25-=?4%E#N*6VB,SJRSKY#<J%.B2$$MF1'
M?:4I#C:TG]0_ _ _$AZ,Y?F%CFUC2S++*M.OE]>"G3J0DI0G&2Q4HM:&F><>
M89??93?5<LS.C4H9A0FX5*<XN,X2B\'&2>E-'U!W#I@    'ELYQY.6X3F&*
M+(E(R;%L@QY:5=/2I-U4RZU1*ZS)'!E)\>?#]T8;>/*UGF[U_DLO)O+*O0?[
M6E*GPZ/?<)F=W,T>1[PV&=1T2L[VA77[*K&IP:?>\!5 6A;:UMN(4AQ"E(6A
M:32M"TF:5(6E1$I*DJ+@R/Q(QXG2C*$G&2:DG@T]:?$SVVC*,XJ46G%K%-:F
MN-'_  /P_29OTN<E*1A^U<.4X1'49+19*TT:^#4615<BKD.-MF?)DW\EVB69
M%X=2>?A(;^>QMFZJY#G60MZ:%W1N$L=?7TY4Y-+D]'CB^58\!H![9>4.EGV2
MY\EHKV=:W;PU=14C4BF^7TB6"Y'AJ9*@-SS2X          \_EN44F#XKDV:
MY--;K<;Q#'[G*,@L7?\ 95])C]=)MK6:YXE]CBP(CCA_Z$CDHTJEQ6A0I+&K
M.2BEQMO!+NGQ4G&E"52;PA%-OF6EG.MWAM6[WEN'9FW\A\U-KL;-,@RQZ,Z^
MJ3[MCVUB_(KJ5AY1)-4.CK5,PV"X(DLL((B(BX&RUA9T["RI65+R*5-1Y\%I
M?.WBWRLJ:YKRN;B=Q/RIR;[O!T:BV'Z&&@?P9=JMGMRU@E'R3?>4/7$9YQMM
M$DL$PYV;CV+L+^%Y*)%N=M-1R9$MB4THBXX4JG]_\Q]*S=6<'C2MX8?'E@Y=
M[97.F3G=JUZFQ=>2\>K+'XJT+OXOI)KQ!21@           1C=YOI6=N?=LS
M;91#K&-2;GEI=?:V5AU:PAF[GFATT*SW%FG8=9E27G7"-V61QK4R0A/M?EI\
MLY5D>]V9Y,U2D^NL5[R3U+\26EQYM,>3'28;,<DM+].:75W'PDM?G+4^?7RE
M1+NE[0]W]GN>GA6W<<5":EJ>?Q3,Z=3TW#\Q@,+(CG8]<^4SR^SRDWXCZ&)L
M4U)\UI*5H4JYLISJPSJWZ^REBUY47HE%\37@:Q3X&0*]L+G+ZO5W"PXFM3YG
M^#6C"^?[(S7:5S#R38%_-RG)(E#38XYD-LOVJ\LZS'8::RD]]6:^9=Q-KJAE
MF&B3(4X^J-':0I:N@C'>MK6A:0=*VBH4G)RV5J3EI>"X$WB\%HQ;.O5K5*\M
MNJW*>"6+UX+0L7PZ-!X<=@X@    "R?^S];^.-;;E[9;B:9,V<>-N'!X[BDI
M;1/@^[\6SV,VI1<NR9T)VE?;:29=+<.0O@_C&57]HV78PH9K!:4^KGS/&4.X
M]I=*)ANK=82J6<GH?CQ\$OP=QEG<523,     YK^:?=CEGSFOOMI*&T-#ZF'
MFKP%/U/K)><_">9'*?    29>CQ^L:[=ORN?05LX17?7^F;G]G^]IF9W?];T
M?C?,D7E!0990             1Y^JW^KY[E/FSB_TB8>)+NA_4EKYTOF2,3G
MGJJMYJ^<BB*-@2L@    "S'^SK?WPO\ +[_3<*L[2_X+]M_E$RW2_B/B?XRS
M&*L)B          4:_6'_6-=Q/Y(_H*UB+\W*_IFV_:?O:A6N\'K>M\7YD2,
MT2HPP   >FPO[L<3^<U#]M(HXJ_U,_-?@/NG]9'SEX3I0#5XN      YZ7>I
M^>/W:?\ $SOCZ4\J&R.1>I+/^5I?NXE4YCZPK_KI_.9K,,J=(   -O\ T_\
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MPV,QKQ6KK9=]MFJ0S!T0   SGVP_G*]O/X\M2_?]0#'YKZKN?Y>I\QG9LO\
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M<]X[R3L-O:A;4L:=M3XL*:?CN/!.JZE3#1MX&<Q8Q7
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M6LS,^3,S&M-S<5+JXJ759XU:DW)\\GBRVJ-*%&E&C#R(Q27,E@>Q' <@
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M[B]K)XQ4Y>)#'7U=*.S2II\5.$5R&01*"+@
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M*2?5[4\9;6EMX+DT+'I1E,CO+N^MI5[K##;PC@L-2T]]X=!*4(D9LCS]5O\
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M   $F7H\?K&NW;\KGT%;.$5WU_IFY_9_O:9F=W_6]'XWS)%Y04&64
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MJBZ7!I=]H[V61<LQH):^M@^Y)-]XZ#0UQ+5
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MRQC'H;VGSQ1E]U;7:J5+R6J*V5SO2^XL.Z6D!4Q-0
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M]3UF.VHK':V,,-F4O@O''#@,_D>57&6=;U\H/;V<-EMZMK''%+C)?A"S/@
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MQD\6IMZD\-#TF0RO(+RROH7565)TX[6.#ECIBUPQ2UOC+'HK$EP
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MG4I3BL8PPQE%I8_2/1ITZ&<UONS?TJ\*LIT=F,TW@Y<#3^"6M!4).
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M7BPN[2XJ49K5A.E.4)+#@\:+/MC(F.
M                       #^;K33[3C+S;;S+S:VG6G4)<:=:<2:'&W&UD:
M%MK09D9&1D9'P8)M/%:QKT/4>-L-::YMVD,6N 839LMN>:VS88K136FW>E2/
M,0W)@.(0YT*,N2+G@S(<\;JZ@\85*B?))K\)QNC1EY4(OH1^JKP'!:1,=%+A
M>)U"(;Q2(B:O'*>O3%D)=\]+\=,2&T3#Q/?')2>%=7CSR/R=Q<5,>LJ3ECKQ
MDW^$1I4H^3&*YDCU@X3D
M                                                  /YNM-/M.,O
M-MO,O-K:=:=0EQIUIQ)H<;<;61H6VM!F1D9&1D?!@FT\5K&O0]1CFVTQIZ^.
M2J\U1K6Z5-2E$P[;!<7L3EH0A#:$23F5;QOI0VVE)$ODB2DB^ B':A?7M/#J
MZU6.&K"<EAW&<,K>WEY4(/GBO</-L=LW;?&>9DQNWW2,>1'=;?8?8U1@;3S#
MS2R<:>9=;H4K;=;6DE)4DR,C+DARO-<T:P=S<-/_ *D_=/A6=HGBJ5/'S8^X
M9)H,+P[%"66+8GC6-$X2TN%04573DXEU32G27[NBQNHG%,(-7/PFA//P$.K4
MKUZWUTYSYVWX3FC3IP\B,5S)(]*.(^P
M                                               /(YW@V,[)Q.ZP
MG,*UNTQ^^B*B38RC-#B#)27(\N(^GX\6="D(2ZRZGXS;B",A@]Y-W,GWMR2X
MW>SZDJV5W,-F<7H:X8RB]<9PDE*$EIC))F=W:WDSC='/+?>'(:KHYI;3VH26
ME/@E&2U2A.+<9Q>B46T5N^X?0N2]ON?2L5N/,GTDWSIV(Y(3"FHU_3$X24K/
MP-MFT@=:6YC!*/RG#(R,VUMK7Y-=J?9IF_9?O-/);_&KE]3&=M7PPC6I8]Q5
M(8J-6";V98-8PE"4O6CLK[3,H[4-V(9U884LQIX0NJ&.,J-7#5QNG/!RI3:6
MU'%/"<9QC@85J66?T:==8=;?8<<9>9<0ZR\TM3;K3K:B6VXVX@R6AQ"R(R,C
M(R,N2'U"<Z<U4IMQJ1:::>#36E--:4T]3/F<(5(.G42E3DFFFL4T]#33T--:
MT259/NAON>[1,AH,G>;=V]I630Y<ZXYTE(RS&X3WR?G9''/Z\YD:LN7%6;9?
M$\UMMXN"=)#>V^<=H$>V+L,NLLSB2>_6[TZ-TV_*N:$'U$Z\>':C3JR=Q'5M
M1C46"FHPU&R;L_EV.=NEKF>3Q:W$WAA6M4EY-M7FNOA0EP;,JE**MY:]F4J>
MG8<IQHC48V[  L-]@V=_+3MQQF$\\;UC@MC;87--2C-?E07D6=.1)5XI:9HK
M:,RD_%)FR?!^!D7J7[,V\GW@[*+.WJ2VKK+:M2TGQX0:J4NA4:M.*X/%?$TO
M+#VFMVON_P!K%Y<4X[-KF5*G=PXL9ITZO2ZU*I)\/C+C3>Z V -?@
M
M
M
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M[E>]E&.-2SN9V]1I:>KN([4'+\6%2ELK3Y57AQT32CT#//D
M
M
M
M                                             -)>]#MB8WGAOREQ
MF&VG:&'0GUTJVTH;<R6H0I<F3BTMS@C<=-:ENP%+/I:DJ4CXJ7W%%KS[0'8_
M2[1\@^U\GII;XV%-NDU@G<4EC*5O)\+QQE1;T1J.4="J29L/[/W;%5[-\_\
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M;K4<*U%+SJD(Q;6G!OF+0(]BCQQ
M
M
M
M                           (;O4([9"IY;^^<'KNFLLI+;>QJR(T9(@6
M<EPFHN6-M-IZ41;1]269I^'3*4V[PHWG%(T(]J+L@5C7EVE;N4L+.K-*^IQ6
MB%23PC<I+5&H\(U>*HXST]9-QWY]EOM@=_0CV:;QU<;RC!NPJ2>F=.*QE;-O
M7*FL9T>.FI0T=7!2BE&E9NN     6;^U_8?X4-$:XRIZ0<FS.@8I+UQQ74^N
M]QQ2Z2S?D%U*-+L]^#[27/PH>2?P&/7_ +'=Z?OCV;93G52>W>>C*E6;UNM0
MQHU'+EFX=9RJ:?">/G;'NK]S>TK-LEIPV+/TEUJ*6KJ:^%:FH\D%/J^1P:X#
M/@LPK(
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MJ/NC^U!VT_XA]&?SM8#_ !@#[)S7_;7'_;G[@]-L_P!+2^5'W3.8QYV0
M  /D7V04.+5$_(,GNZC'*&K9]HL[N^LH=145T?K0WY\^RL'H\*(SYCB4]3BT
MIZE$7/)C[ITZE::ITHRE4>I)-M\R6EGS*<81<YM**UMZ$8C_ +4';3_B'T9_
M.U@/\8!W?LG-?]M<?]N?N'!Z;9_I:7RH^Z9=H[ZCR>H@7^-7-3D-#:L%*J[N
MCL8=M46492E)3(@64!Z1#F,*4DR);:U),R/Q'2J4ZE*;IU8N-1/2FFFN=/2C
MGC*,XJ<&G%ZFM*/K#X/H
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MT\$5KX);!O :.@
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MW43XBO"4
M                       &OW<MHRKW[K"UQ-\F(^1P27<89;N)22JW(8S+
MA,,NN\&I-;;(,XTHO$B;<)PDFXVV95AVN=G%EVF[G5\DJ;,,UIXU;6J_^77B
MG@F_T=1?1U%I\5[23E".%H=D7:1>]F.^-#/*>U/*:F%*[I+_ )E"36+2U=92
M?TE-Z/&6PVHSEC6GN*BSQ^VLJ*ZA/UMO3SY=9:5\I'1(A3X+ZXTN*^CD^EQA
M]M23X,RY+P'D=?V-YE=[6RW,*<J-]0J2IU(26$H3@W&46N---,]=;"^L\TL:
M.99?4C6L+BE&I3G%XQG":4HR3XFFFCYHZAVP -ANU;92=4[WP#*),@X]._:E
MCV0J-24LE29&@ZF5(D&HT_8*QV2W,/QYZHY?#\!VEV+[W+<KM)RS.:TMFPE7
MZBOQ=37752E+DIN4:O/37,59VT[HO?;LUS3)J,=J_C0Z^AQ]=0?6QC'EJ*,J
M7-4>K6691Z\GD$
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M^)1J%^E:E[KTI/U?/;7\V<H^D3,!K]O?_4EUYT?F1+-R/U51\U_.9(8(T98
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MZNO2S:FO%J+JY^<M,7SN.*YHHF.ZUWM4YV4GIB]J/,]#[CP?26+169+0
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MM
M                  "(3U&^WKREL;]Q6#]C=5"I]CQHS?@AT_+A4>5+))<$
MEX_+@2E<E\?V8R29J=4-%O:N[+=B4>TW):?BO8I7T8K4]$*-R^?Q:-1\?4M+
M%S9O9[)_:GMQEV8YU4\9;=6PE)ZUIG6MES>-6IKBZY-X*$2(\:.F\@   6;>
MU_9A;9T9@&6OOD_;E4(HLC,W"<>^4&/*.IL7Y!$1>4Y9JC)F)2?P-R4_#SR/
M7[L=WN^^_9SEF>5);5]U"HU].+Z^A]%4<N)U-E54O@U$>/O;'NA]R.T?-,CI
MQV;#KW6H:,%U%?Z6FH\:I[3I-_"ILS\+-*Q
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M.*9\F9GQ<W9Y>SKY54M)O'J*GB\D9K'#Y2D^D@6]%O&G>1KQT=9#3SQT8]S
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M4*CZR'FR;T=$L5S)%G9+=^F9?";>-2/BRYUP]*P?22#B-F5
M
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M:.&8D;Y&A8
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MR97QS^2Q^G$[#O\ O_9O\W%C_P!L#[A;P_!I?+7N#[R97QS^2Q^G$[#O^_\
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MGPJ7<-REO$I/%OJIMON:637>3!96TM"VXE,(7B5X=,8:LEQ@    %.7UQNY
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MCI7=6/3@6]13)/0
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MD.(
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MV5;ZRE-Q?+@]#YFM*Y&6S;5X7-"%Q#R9Q3[O!T:C)PZIS
M
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MO#9RS-8^ET\%H52;:N(XK1CURE4:X(U88XZWND-@37T
M                                                   *;OKP_GN5
M7XC<#^^#.!=O9]ZA?\Q/P1*^WG]9+]5'PLBQT=I_)=_;:P336'3J*MR?85ZU
MC]+/R:3/AT,6:\R^^EVTE5=9<V#,4D,&1J:BOKY,OBB6W][2RZSJ7U=2=*E'
M%J.#>')BTN^C"6UO.ZKQMZ;2G-X+'5TX)^ EU_0 =X_\I7;-_#+:?]3(AO\
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M;7Z.:;2E4Q<7HDOJ^&+:.K>[P9;>6E2V<*WC1T:(Z'K3\O@>#*P0M<A9:^]
M[N-++-2[ [:;VP2NYU7:KS?"(SSR?/>P/,)AE>PX<?Z]47'<S4I]YSZB[QM/
MP$0J#M#RSJ;RGFE->)66S+SXK0WYT="\QDYW7N]NA.SD_&@\5YKU]Q^$L$"N
M"5
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M;:&UF635.O6"Q;H3PA<1YDMBM)\"HOC)^!Z;'F,
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M,E)41*2I)D:5),N2,C+P,C(:ZEI'^@
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M*6$Z,_CTI0D\-3;7 9,$O(@
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M.+ LS([OTO+X.3^DAXKZ-3Z5ATXDCXC!EP
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M63-'/:_W%<Z=CVA64-,,+2ZPXFW.WJ/!<#=2G*3?#2BB7T;U&B0
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M:5W5BNX6S!3Q.@
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M2?.?8'?.@
M
M
M
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MVVD<++-Z3ZS#@N:"C&;P6I5*;I2XY351XDC8VN-3P
M
M
M
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MOM]<IS*^R[<O+YQJWMC.I6N7%XJG*<8QITGA[_9VISB],4Z?PFE*J-T32L
M
M
M
M
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MTMO6?T'V?
M
M
M
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MCNIJ2QB\4S]0_#]
M
M
M
M                 @-]4SU7K+0-S8]N_;=.K7=L,1T)V#L92(UI&ULN4REY
MK&Z&NEQ9%98YF]%>0[(?>-V/5H,FC:<E+7[)8FZ6Z$<Q@LRS1/T-OQ(:MO\
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MTFR8Q9W
M
M
M
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MEQP4F6
M
M
M
M     $=?JRU5E<^GKW)1*E;S<IFBPRU=4P;A+.MHMG81=W2%&TI*O)<IZY]+
MA'\4VS5U$:>2$EW/G&&\EK*>K:DNETY)=]HQ.>Q<LIK*.O!/N23?>*)HV!*R
M     -]O2^K;"U[^NV6+6,.R)+6>2;)QMGGK37TV,7]Q;/GQX^5%JH+SB_J=
M"#Y\!'=ZY1AN[=.>A=7ATN22[[1E,E3EFE%+7M>!-OO%] :]EG@
M
M
M
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MROA?1JZ7Q%H85030
M
M
M
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M:M5N*LJ]>3G6F\6WI;;X636G3A2@J=-*,(K!):DCT(XC[
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                          #_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>atha-20210513.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-05-12T20:21:22.8744962+00:00 -->
<!-- Version            : 5.0.1.615 -->
<!-- Package ID         : 06e9c7c3886d43f3885db2f48ff1ed74 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:atha="http://m3bio.com/20210513" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://m3bio.com/20210513" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" namespace="http://xbrl.sec.gov/country/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd" namespace="http://fasb.org/srt-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" namespace="http://fasb.org/srt-types/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" namespace="http://fasb.org/us-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://m3bio.com/20210513/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="atha-20210513_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="atha-20210513_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>atha-20210513_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-05-12T20:21:22.8744962+00:00 -->
<!-- Version            : 5.0.1.615 -->
<!-- Package ID         : 06e9c7c3886d43f3885db2f48ff1ed74 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>atha-20210513_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-05-12T20:21:22.8744962+00:00 -->
<!-- Version            : 5.0.1.615 -->
<!-- Package ID         : 06e9c7c3886d43f3885db2f48ff1ed74 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://m3bio.com/20210513/role/TemplateLink" xlink:href="atha-20210513.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="atha-20210513.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>atha-8k_20210513_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="atha-20210513.xsd" xlink:type="simple"/>
    <context id="C_0001620463_20210513_20210513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001620463</identifier>
        </entity>
        <period>
            <startDate>2021-05-13</startDate>
            <endDate>2021-05-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001620463_20210513_20210513" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001620463_20210513_20210513" id="F_000004">0001620463</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001620463_20210513_20210513" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001620463_20210513_20210513" id="F_000002">2021-05-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001620463_20210513_20210513" id="F_000003">Athira Pharma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001620463_20210513_20210513" id="F_000005">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001620463_20210513_20210513" id="F_000006">001-39503</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001620463_20210513_20210513" id="F_000007">45-3368487</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001620463_20210513_20210513" id="F_000008">18706 North Creek Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001620463_20210513_20210513" id="F_000009">Suite 104</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001620463_20210513_20210513" id="F_000010">Bothell</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001620463_20210513_20210513" id="F_000011">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001620463_20210513_20210513" id="F_000012">98011</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001620463_20210513_20210513" id="F_000013">425</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001620463_20210513_20210513" id="F_000014">620-8501</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001620463_20210513_20210513" id="F_000015">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001620463_20210513_20210513" id="F_000016">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001620463_20210513_20210513" id="F_000017">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001620463_20210513_20210513" id="F_000018">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001620463_20210513_20210513" id="F_000019">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001620463_20210513_20210513" id="F_000020">ATHA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001620463_20210513_20210513" id="F_000021">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001620463_20210513_20210513" id="F_000022">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_0001620463_20210513_20210513" id="F_000023">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139761253747256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 13,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Athira Pharma, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001620463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-3368487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">18706 North Creek Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bothell<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">620-8501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATHA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " !6@:U2!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( %:!K5*AH9"K
M[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( %:!K5*97)PC$ 8  )PG   3              "  <P!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 5H&M4N'NL/IO!   A1$
M !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( %:!K5*?H!OPL0(  .(,   -              "  ;(,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ 5H&M4I>*NQS     $P(   L
M         ( !C@\  %]R96QS+RYR96QS4$L! A0#%     @ 5H&M4APX9>H_
M 0  / (   \              ( !=Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( %:!K5(D'INBK0   /@!   :              "  >,1  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( %:!K5)ED'F2&0$
M ,\#   3              "  <@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  !(4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="atha-8k_20210513.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="atha-8k_20210513.htm">atha-8k_20210513.htm</File>
    <File>atha-20210513.xsd</File>
    <File>atha-20210513_lab.xml</File>
    <File>atha-20210513_pre.xml</File>
    <File>atha-ex991_67.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "atha-8k_20210513.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "atha-8k_20210513.htm"
     ]
    },
    "labelLink": {
     "local": [
      "atha-20210513_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "atha-20210513_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "atha-20210513.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "atha",
   "nsuri": "http://m3bio.com/20210513",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "atha-8k_20210513.htm",
      "contextRef": "C_0001620463_20210513_20210513",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "atha-8k_20210513.htm",
      "contextRef": "C_0001620463_20210513_20210513",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://m3bio.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-21-027547-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-21-027547-xbrl.zip
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MN3,#(NX4=/<I=V3Q -V$>SC(#V&/3K]X!+84K1$-BKG!5:*"6ZY #R:X,QH
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M0#LY&9% <V@(XD\O=!D8E1Y:#YQ(FZND QKAR(<Q>CH:J7X@ !7N#Y^47Z+
M=1QWK*V^=25QQ[.V5-OL/3TW0MSL73VKNGI]E'K["_@+OZZSZG3+>^&.Y^YJ
M*\KO:%>;2*RE7]PUYV2SZL\Z8\UXM/I^QS6]4?@VKB)^\JZUXJ1A[<5X_AB9
MQ?P!T.JL[O/0^Y&X]I?A:GC67HQGUU:#L#$(K<@*^<:83[[2!RI?I(#?K]W<
M!BOOA5(OD?*/*\1; =X*\#NAU%: 9UQ1)SG"I4\PVWW.>N1L]#&/"_TQ#[',
MH3,>51OI!_K"!2*7#W'L\;Z/T:IOA,&C2C=PAYJ=^FK@P1__ 5!+ P04
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M!?,Y-2OI!=+B)C!B;!X3&-DLFP?3F#I<[;YE/T)F1V-I2B^R7N#U)>;3MFI
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MS#CD/95?&+KT,7USRBA<L,M%0G17D@Q*N$?R-'D.6-;&W );IP-DFS[T]LA
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M+ TIV5N+2;A9I7VL0JT2??+EKK-D'VNH.*=N9"3?5Z5!C6W[58>#C>=N9QN
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MAL?;#IS'3W^'P78CSX4/_P]02P$"% ,4    " !6@:U2%>^BG:X$  "A%@
M$0              @ $     871H82TR,#(Q,#4Q,RYX<V102P$"% ,4
M" !6@:U2, DYCET'  !V3P  %0              @ '=!   871H82TR,#(Q
M,#4Q,U]L86(N>&UL4$L! A0#%     @ 5H&M4E%14^D>!0  6B\  !4
M         ( !;0P  &%T:&$M,C R,3 U,3-?<')E+GAM;%!+ 0(4 Q0    (
M %:!K5*-&D,/:Q(  %V2   4              "  ;X1  !A=&AA+3AK7S(P
M,C$P-3$S+FAT;5!+ 0(4 Q0    ( %:!K5(!9G=H(R$  $<O @ 1
M      "  5LD  !A=&AA+65X.3DQ7S8W+FAT;5!+!08     !0 % $8!  "M
%10     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
